Medivid

Colecalciferol, the active ingredient in Medivid, is a vitamin D presented as an oral supplement for oral use. It is used to correct vitamin D deficiency and to aid calcium absorption in individuals with low dietary intake or limited sun exposure.

GNH USA supplies Medivid as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company follows EU quality standards and provides reliable global distribution for this vitamin D product.

Medivid (colecalciferol) is used in the management of disorders related to insufficient vitamin D and calcium metabolism.

- Vitamin D deficiency: restores normal serum 25‑hydroxyvitamin D levels and supports bone health. - Calcium deficiency: enhances intestinal calcium absorption to improve calcium balance. - Osteomalacia/Rickets: promotes mineralisation of bone matrix in adults and children with defective mineralisation.

Adverse reactions to oral colecalciferol are generally uncommon but can occur.

Common Side Effects: - Nausea: mild gastrointestinal upset. - Constipation: occasional bowel changes. - Hypercalcemia symptoms: fatigue, headache. - Metallic taste: transient oral sensation. - Skin rash: mild dermal irritation.

Serious or Rare Side Effects: - Severe hypercalcemia: confusion, arrhythmia, renal impairment. - Hypercalciuria: kidney stone formation. - Allergic reaction: hives, swelling, anaphylaxis. - Hyperphosphatemia: muscle cramps, joint pain. - Persistent vomiting: may indicate toxicity.

When using Medivid, consider the following safety measures.

- Assess baseline vitamin D levels: determine need for supplementation. - Monitor calcium status: avoid concurrent high‑calcium diets or supplements. - Renal impairment: adjust use under medical supervision. - Hyperparathyroidism: use only if advised by a clinician. - Pregnancy and lactation: consult healthcare professional before use. - Store at ambient temperature: keep below 25 °C, retain original packaging, protect from moisture and direct sunlight.

Colecalciferol may interact with several medicines, requiring attention to avoid altered efficacy or toxicity.

Major Interactions (Avoid): - Thiazide diuretics: increase risk of hypercalcemia. - Vitamin A excess: synergistic hypercalcemia risk. - Lithium: may exacerbate lithium‑induced hyperparathyroidism.

Moderate Interactions (Monitor Closely): - Anticonvulsants (e.g., phenytoin, phenobarbital): may reduce vitamin D levels. - Glucocorticoids: can impair vitamin D metabolism. - Orlistat: decreases absorption of fat‑soluble vitamins including vitamin D.